Skip to main content
HR 2379 117th Congress House Health Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Health care coverage and access Health care quality Health programs administration and funding Health promotion and preventive care Prescription drugs State and local government operations

State Opioid Response Grant Authorization Act of 2021

Introduced: April 8, 2021 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 18 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 21, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct 20, 2021
Motion to reconsider laid on the table Agreed to without objection.
Oct 20, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320). (text: CR 10/19/2021 H5647-5648)
Oct 20, 2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320).(text: CR 10/19/2021 H5647-5648)
Oct 20, 2021
Considered as unfinished business. (consideration: CR H5699-5700)
Oct 19, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-149.
Oct 19, 2021
Placed on the Union Calendar, Calendar No. 109.
Oct 19, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Oct 19, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2379.
Oct 19, 2021
Considered under suspension of the rules. (consideration: CR H5647-5650)
Oct 19, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Apr 13, 2021
Referred to the Subcommittee on Health.
Apr 8, 2021
Referred to the House Committee on Energy and Commerce.
Apr 8, 2021
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Oct 20, 2021 House · vote #320 On Motion to Suspend the Rules and Pass, as Amended Passed 380–46 See who voted →
 Plain-English summary Congressional Research Service

State Opioid Response Grant Authorization Act of 2021

This bill reauthorizes through FY2027 and otherwise changes the State Opioid Response Grant program. This program, which is managed by the Substance Abuse and Mental Health Services Administration, provides funding for states, territories, and Indian tribes and tribal organizations to address the opioid crisis.

Specific changes to the program include (1) expanding its scope to also address stimulant use and misuse, (2) establishing a funding methodology and minimum funding allocations, and (3) allowing the use of grant funds for recovery support services.

The bill also requires the Government Accountability Office to report on issues concerning the funding and other aspects of the program.

What's happening now October 21, 2021

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 3
 Cosponsors 5
All 5 Democratic 1 Republican 4